{"CONCEPT_ID":[836654],"CDM_TABLE_NAME":["DRUG_ERA"],"CONCEPT_NAME":["tacrine"],"NUM_PERSONS":[5],"PERCENT_PERSONS":["0.0029"],"RECORDS_PER_PERSON":[" 1.0"],"AGE_AT_FIRST_EXPOSURE":[{"CATEGORY":"MALE","MIN_VALUE":79,"P10_VALUE":79,"P25_VALUE":79,"MEDIAN_VALUE":79,"P75_VALUE":79,"P90_VALUE":79,"MAX_VALUE":79},{"CATEGORY":"FEMALE","MIN_VALUE":16,"P10_VALUE":16,"P25_VALUE":76,"MEDIAN_VALUE":84,"P75_VALUE":84,"P90_VALUE":85,"MAX_VALUE":85}],"PREVALENCE_BY_GENDER_AGE_YEAR":[{"TRELLIS_NAME":"80-89","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":1994,"Y_PREVALENCE_1000PP":50},{"TRELLIS_NAME":"70-79","SERIES_NAME":"MALE","X_CALENDAR_YEAR":1994,"Y_PREVALENCE_1000PP":35.7143},{"TRELLIS_NAME":"10-19","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":1995,"Y_PREVALENCE_1000PP":20},{"TRELLIS_NAME":"80-89","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":1995,"Y_PREVALENCE_1000PP":45.4545},{"TRELLIS_NAME":"70-79","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":1996,"Y_PREVALENCE_1000PP":58.8235},{"TRELLIS_NAME":"80-89","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":1996,"Y_PREVALENCE_1000PP":45.4545}],"PREVALENCE_BY_MONTH":[{"X_CALENDAR_MONTH":199409,"Y_PREVALENCE_1000PP":1.1933},{"X_CALENDAR_MONTH":199509,"Y_PREVALENCE_1000PP":1.1669},{"X_CALENDAR_MONTH":199404,"Y_PREVALENCE_1000PP":1.2048},{"X_CALENDAR_MONTH":199606,"Y_PREVALENCE_1000PP":2.2883}],"LENGTH_OF_ERA":[{"CATEGORY":"Length of Era","MIN_VALUE":325,"P10_VALUE":325,"P25_VALUE":343,"MEDIAN_VALUE":352,"P75_VALUE":354,"P90_VALUE":359,"MAX_VALUE":359}]}
